Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.
Treatment with GLP-1 RAs for T2D and obesity is independently associated with an increased risk for osteoporosis, gout, and osteomalacia.
Current smoking in GD is linked to higher TRAb levels, increased odds of orbitopathy, and higher 12-month relapse risk after drug withdrawal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results